MedPath

Laboratoire Schmidt-Nagel Inc

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

FDA:13

Drug Approvals

Hypericum Perforatum 30X

Approval Date
May 20, 2025
FDA

Arsenicum Album 30X

Approval Date
May 20, 2025
FDA

Belladonna 30X

Approval Date
May 20, 2025
FDA

Gelsemium Sempervirens 30X

Approval Date
May 20, 2025
FDA

Chamomilla 30X

Approval Date
May 20, 2025
FDA

Ignatia Amara 30X

Approval Date
May 20, 2025
FDA

Nux vomica 30X

Approval Date
May 20, 2025
FDA

Rhus Tox 30X

Approval Date
May 20, 2025
FDA

Coffea Cruda 30X

Approval Date
May 20, 2025
FDA

Lycopodium Clavatum 30X

Approval Date
May 20, 2025
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.